Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2024 Earnings Call Transcript March 13, 2025
Akebia Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.05.
Operator: Good day, and welcome to Akebia’s Fourth Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there’ll be a question-and-answer session. Instructions will be given at that time. As a reminder, this call may be...
